相关实验视频
Updated: May 12, 2025

10:37
Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
21.4K
细胞内膜网膜蛋白29在小鼠中负面调节血小板功能和血栓形成
Xiaofeng Yan1, Yishan Lu1, Keyu Lv2
1Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Prevention, Cyrus Tang Medical Institute, The Fourth Affiliated Hospital of Soochow University, Soochow University, Suzhou, Jiangsu, 215123, China.
Thrombosis journal
|May 7, 2025
概括
蛋白质二硫化异构酶ERp29负面调节血小板功能和血栓形成. 缺少ERp29增强了血小板聚合和血栓形成,突出了其在血液静止的氧化还原控制中的作用.
科学领域:
- 生物化学和分子生物学
- 血液学和血栓症研究研究
- 细胞再氧化生物学 细胞再氧化生物学
背景情况:
- 蛋白质二硫化异构酶 (PDI) 家族的成员,以CXYC活性基因为特征,对通过氧化还原调节的血小板功能和血栓形成至关重要.
- 缺少CXYC动机的PDI家族成员 (如ERp29) 在血小板生物学和血栓形成中的作用在很大程度上仍未被探索.
研究的目的:
- 研究ERp29在血小板活性中的功能及其在血栓形成中的参与.
- 阐明ERp29影响血小板氧化还原平衡和功能的机制.
主要方法:
- 使用尾部出血试验和动脉/静脉血栓形成模型,生成和分析血小板特异性ERp29缺乏的小鼠 (Pf4-Cre/ERp29fl/fl).
- 在体外评估ERp29缺乏的血小板功能,包括聚合,粘附,扩散,凝块收缩,颗粒分泌和整合素αIIbβ3激活.
- 使用3-(N-maleimido-propionyl) 生物素 (MPB) 标签评估整合素αIIbβ3硫醇的氧化还原状态.
主要成果:
- 缺乏ERp29的小鼠表现出血静止受损,其特点是动脉和静脉血栓形成模型中的出血时间缩短和血栓形成增加.
- 缺乏ERp29的血小板表现出增加的聚合,ATP释放,扩散,凝块收缩,整合素αIIbβ3激活,纤维原结合和P-选择素表达.
- 在ERp29缺乏血小板的整合素αIIbβ3中增加的自由硫醇含量表明ERp29在氧化整合素子单元的功能性二硫化物中的作用.
结论:
- ERp29被确定为第一个CXYC负的二硫化异构酶,对血小板功能产生负调节.
- 这项研究揭示了ERp29在通过整合素功能的氧化还原调节来控制血小板活动和血栓形成方面的关键作用.
- 这些发现为复杂的氧化还原网络提供了新的见解,该网络控制了血栓形成和血液静止.
相关概念视频
Structure and Function of Platelets
884
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
884
Anticoagulant Drugs: Low-Molecular-Weight Heparins
546
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
546
Formation of the Platelet Plug
3.1K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
3.1K
Clot Retraction and Fibrinolysis
2.8K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
2.8K
Role of ER in the Secretory Pathway
4.9K
Eukaryotic cells have a special pathway that enables communication between various intracellular membrane-bound compartments and also with the extracellular environment. This pathway is termed as the secretory pathway.
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
4.9K

